JP2023162257A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023162257A5 JP2023162257A5 JP2023132024A JP2023132024A JP2023162257A5 JP 2023162257 A5 JP2023162257 A5 JP 2023162257A5 JP 2023132024 A JP2023132024 A JP 2023132024A JP 2023132024 A JP2023132024 A JP 2023132024A JP 2023162257 A5 JP2023162257 A5 JP 2023162257A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862640955P | 2018-03-09 | 2018-03-09 | |
| US62/640,955 | 2018-03-09 | ||
| US201862721044P | 2018-08-22 | 2018-08-22 | |
| US62/721,044 | 2018-08-22 | ||
| US201862786598P | 2018-12-31 | 2018-12-31 | |
| US62/786,598 | 2018-12-31 | ||
| JP2020546997A JP7334177B2 (ja) | 2018-03-09 | 2019-03-05 | 抗ｃｄ７３抗体及びその使用 |
| PCT/US2019/020688 WO2019173291A1 (en) | 2018-03-09 | 2019-03-05 | Anti-cd73 antibodies and uses thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020546997A Division JP7334177B2 (ja) | 2018-03-09 | 2019-03-05 | 抗ｃｄ７３抗体及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023162257A JP2023162257A (ja) | 2023-11-08 |
| JP2023162257A5 true JP2023162257A5 (ja) | 2023-12-06 |
Family
ID=67846304
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020546997A Active JP7334177B2 (ja) | 2018-03-09 | 2019-03-05 | 抗ｃｄ７３抗体及びその使用 |
| JP2023132024A Pending JP2023162257A (ja) | 2018-03-09 | 2023-08-14 | 抗ｃｄ７３抗体及びその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020546997A Active JP7334177B2 (ja) | 2018-03-09 | 2019-03-05 | 抗ｃｄ７３抗体及びその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11299550B2 (ja) |
| EP (1) | EP3762030A4 (ja) |
| JP (2) | JP7334177B2 (ja) |
| KR (1) | KR20200128542A (ja) |
| CN (1) | CN111867628B (ja) |
| AU (1) | AU2019231172B2 (ja) |
| BR (1) | BR112020016049A2 (ja) |
| CA (1) | CA3090008A1 (ja) |
| IL (1) | IL276950A (ja) |
| MX (1) | MX2020009366A (ja) |
| SG (1) | SG11202007199XA (ja) |
| WO (1) | WO2019173291A1 (ja) |
| ZA (1) | ZA202004827B (ja) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11786551B2 (en) | 2017-09-26 | 2023-10-17 | The Trustees Of The University Of Pennsylvania | Methods for treating heart disease via redirected T cell immunotherapies |
| IL303087B1 (en) | 2018-02-27 | 2024-08-01 | Incyte Corp | Midazopyrimidines and triazolopyrimidines as A2A /A2B inhibitors |
| CA3100731A1 (en) | 2018-05-18 | 2019-11-21 | Incyte Corporation | Fused pyrimidine derivatives as a2a / a2b inhibitors |
| CN113166153B (zh) | 2018-07-05 | 2024-11-01 | 因赛特公司 | 作为a2a/a2b抑制剂的稠合吡嗪衍生物 |
| TWI829857B (zh) | 2019-01-29 | 2024-01-21 | 美商英塞特公司 | 作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶 |
| JP2022548778A (ja) | 2019-09-23 | 2022-11-21 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 線維芽細胞活性化タンパク質（ｆａｐ）を標的とすることによる腫瘍組織の破壊の方法 |
| JP2022548777A (ja) * | 2019-09-23 | 2022-11-21 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | マウスおよびヒト線維芽細胞活性化タンパク質（ｆａｐ）と交差反応するイヌ線維芽細胞活性化タンパク質に対するモノクローナル抗体 |
| BR112022009317A2 (pt) * | 2019-11-15 | 2022-08-09 | Genzyme Corp | Anticorpos de cd73 biparatópicos |
| WO2021102376A1 (en) * | 2019-11-20 | 2021-05-27 | Abvision, Inc. | Monoclonal antibodies that target human cd47 protein |
| KR20220137013A (ko) | 2020-01-03 | 2022-10-11 | 인사이트 코포레이션 | Cd73 억제제 및 a2a/a2b 아데노신 수용체 억제제 병용 요법 |
| MX2022007575A (es) | 2020-01-03 | 2022-09-23 | Incyte Corp | Anticuerpos anti cumulo de diferenciacion 73 (cd73) y usos de estos. |
| CN115244085A (zh) | 2020-03-31 | 2022-10-25 | 西雅图儿童医院以西雅图儿童研究机构名义经营 | 用于溶酶体贮积病的蛋白质组学筛查 |
| IL297432A (en) * | 2020-04-22 | 2022-12-01 | Akeso Biopharma Inc | Anti-cd73-anti-pd-1 bispecific antibody used |
| JP2023522365A (ja) * | 2020-04-22 | 2023-05-30 | アケソ・バイオファーマ・インコーポレイテッド | 抗ｃｄ７３抗体とその利用 |
| AU2021264006A1 (en) * | 2020-04-30 | 2022-12-01 | Arch Oncology, Inc. | Therapeutic sirpalpha antibodies |
| CN114075289B (zh) * | 2020-08-17 | 2024-07-02 | 中山康方生物医药有限公司 | 抗cd73的抗体及其用途 |
| TW202241441A (zh) | 2020-12-29 | 2022-11-01 | 美商英塞特公司 | 包含ａ２ａ／ａ２ｂ抑制劑、ｐｄ－１／ｐｄ－ｌ１抑制劑及抗ｃｄ７３抗體之組合療法 |
| CN113061177B (zh) * | 2020-12-31 | 2022-07-01 | 浙江大学 | 一种cd73酶活性相关的抗原表位及针对该表位的特异性抗体的制备方法 |
| EP4299589A1 (en) * | 2021-02-24 | 2024-01-03 | Novoprotein Scientififc Inc. | Anti-human cd73 antibody and use thereof |
| GB202105110D0 (en) * | 2021-04-09 | 2021-05-26 | Cancer Research Tech Ltd | Anti-CD73 antibodies |
| AU2022331350A1 (en) * | 2021-08-19 | 2024-03-14 | Adicet Therapeutics, Inc. | Methods for detection of membrane bound glypican-3 |
| CN116265486A (zh) * | 2021-12-17 | 2023-06-20 | 三生国健药业（上海）股份有限公司 | 结合人cd73的抗体、其制备方法和用途 |
| US20230279139A1 (en) * | 2022-03-04 | 2023-09-07 | Development Center For Biotechnology | Anti-cd73 antibodies and use thereof |
| AU2023252914A1 (en) | 2022-04-13 | 2024-10-17 | Arcus Biosciences, Inc. | Combination therapy for treating trop-2 expressing cancers |
| WO2024040194A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5382692B2 (ja) | 2006-07-10 | 2014-01-08 | 学校法人藤田学園 | 抗体の分類法、抗原の同定法、抗体又は抗体セットの取得法、抗体パネルの作成法、並びに抗体又は抗体セット及びその用途 |
| FR3011240A1 (fr) | 2013-10-01 | 2015-04-03 | Centre Nat Rech Scient | Inhibiteurs de 5'-nucleotidases et leurs utilisations therapeutiques |
| MA39986A (fr) | 2014-04-25 | 2017-03-01 | Vitae Pharmaceuticals Inc | Dérivés de purine en tant qu'inhibiteurs de cd73 pour le traitement du cancer |
| WO2016131950A1 (en) * | 2015-02-20 | 2016-08-25 | Innate Pharma | Cd73 blockade |
| MX2017004691A (es) | 2014-10-10 | 2017-10-02 | Innate Pharma | Bloqueo de cd73. |
| CA2967118A1 (en) | 2014-11-10 | 2016-05-19 | Medimmune Limited | Binding molecules specific for cd73 and uses thereof |
| EP3789403A1 (en) * | 2014-11-11 | 2021-03-10 | MedImmune Limited | Therapeutic combinations comprising anti-cd73 antibodies and a2a receptor inhibitor and uses thereof |
| ES2807182T3 (es) | 2014-11-21 | 2021-02-22 | Bristol Myers Squibb Co | Anticuerpos frente a CD73 y sus usos |
| HUE052526T2 (hu) | 2014-11-21 | 2021-05-28 | Bristol Myers Squibb Co | Antitestek, amelyek tartalmaznak módosított nehéz konstans régiókat |
| US11130817B2 (en) | 2015-10-12 | 2021-09-28 | Innate Pharma | CD73 blocking agents |
| AU2016366548C1 (en) * | 2015-12-09 | 2024-07-25 | Bioatla, Llc | Humanized anti-CD73 antibodies |
| WO2017118613A1 (en) | 2016-01-08 | 2017-07-13 | Syddansk Universitet | Bispecific antibodies targeting human cd73 |
| CA3016187A1 (en) | 2016-03-04 | 2017-09-08 | Bristol-Myers Squibb Company | Combination therapy with anti-cd73 antibodies |
| WO2018013611A1 (en) | 2016-07-11 | 2018-01-18 | Corvus Pharmaceuticals, Inc. | Anti-cd73 antibodies |
-
2019
- 2019-03-05 CN CN201980018305.6A patent/CN111867628B/zh active Active
- 2019-03-05 WO PCT/US2019/020688 patent/WO2019173291A1/en active Application Filing
- 2019-03-05 KR KR1020207027633A patent/KR20200128542A/ko not_active Application Discontinuation
- 2019-03-05 BR BR112020016049-0A patent/BR112020016049A2/pt unknown
- 2019-03-05 EP EP19764477.6A patent/EP3762030A4/en active Pending
- 2019-03-05 JP JP2020546997A patent/JP7334177B2/ja active Active
- 2019-03-05 AU AU2019231172A patent/AU2019231172B2/en active Active
- 2019-03-05 SG SG11202007199XA patent/SG11202007199XA/en unknown
- 2019-03-05 US US15/733,540 patent/US11299550B2/en active Active
- 2019-03-05 MX MX2020009366A patent/MX2020009366A/es unknown
- 2019-03-05 CA CA3090008A patent/CA3090008A1/en active Pending
-
2020
- 2020-08-04 ZA ZA2020/04827A patent/ZA202004827B/en unknown
- 2020-08-26 IL IL276950A patent/IL276950A/en unknown
-
2023
- 2023-08-14 JP JP2023132024A patent/JP2023162257A/ja active Pending